Zimbabwe has declined a significant US health deal valued at 367 million US dollars (£272m) spanning five years due to the United States' request for confidential data.
This move was revealed after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson has since clarified that the US was demanding access to biological samples for scientific study and commercial gain while refused to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued talks to find a agreement agreeable to all parties so the nation's vital HIV treatment initiative can continue.
Wider Background
Zimbabwe's decision comes after a similar situation in Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the security of Kenyans' health data.
Since returning to office last year, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was seeking government-to-government agreements to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have to date signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery without any certainty that the final treatments would be available to our citizens if a future pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were upending systems already established via the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential pandemics.
"This system is intended to guarantee that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We encourage continued dialogue with our American counterparts on how subsequent co-operation might be designed in a way that honours the sovereignty and dignity of both nations."
Health Experts Response
A leading public health body stated it understood the official position, but recommended that talks need to persist since much of the country's HIV programmes were funded by foreign aid.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can often be addressed through detailed discussion and negotiated safeguards," it added.
This impasse underscores the continuing challenges between receiving crucial foreign assistance and protecting local interests in an ever more data-driven world.